Azatadine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Azatadine
Clinical data
Trade namesOptimine
AHFS/Drugs.comMicromedex Detailed Consumer Information
ATC code
Identifiers
  • 11-(1-Methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
CompTox Dashboard (EPA)
  • {{#property:P3117}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC20H22N2
Molar mass290.410 g·mol−1
3D model (JSmol)
  • n4c3\C(=C1/CCN(C)CC1)c2ccccc2CCc3ccc4
  • InChI=1S/C20H22N2/c1-22-13-10-16(11-14-22)19-18-7-3-2-5-15(18)8-9-17-6-4-12-21-20(17)19/h2-7,12H,8-11,13-14H2,1H3 checkY
  • Key:SEBMTIQKRHYNIT-UHFFFAOYSA-N checkY
  (verify)

Azatadine (Optimine) is a first-generation antihistamine and anticholinergic drug that was synthesized in 1963 by Schering-Plough, a former American pharmaceutical company.[1][2] It is a nitrogen analog of cyproheptadine.[3]

It was patented in 1967.[4] It has been succeeded by both loratadine and desloratadine.[5]: 53  and marketing approvals have been widely withdrawn.[6][7][8][9]: 290 [10]

Pharmacology

[edit | edit source]

Azatadine exhibits potent antihistamine[11], anticholinergic, antiserotonin, and antianaphylactic properties. Its anticholinergic potency is one-third that of atropine and equivalent to that of promethazine and cyproheptadine. Azatadine is among the more potent antianaphylactic agents.[3]

Azatadine is a first-generation antihistamine.[12]

Field of application

[edit | edit source]

The medicinal form of azatadine is the salt of maleic acid, azatadine maleate. It is described as an effective treatment for acute and chronic allergic rhinitis[11], vasomotor rhinitis, urticaria, and certain forms of atopic and contact dermatitis. At the maximum recommended therapeutic dose of 4 mg per day, the drug markedly reduced the severity of perennial allergic rhinitis in most patients (80%) over a 7-day period and significantly decreased swelling in histamine provocation and allergen tests. It was generally well tolerated. Drowsiness was reported by 40% of patients.[13]

Mechanism of action

[edit | edit source]

Antihistamines such as azatadine compete with histamine for the histamine H1 receptor on plasma cell. This antagonism counteracts the pharmacological effects of histamine mediated through H1 receptor activation, thereby reducing the intensity of allergic reactions and the tissue damage associated with histamine release.[14] In addition, azatadine has been shown to downregulate leukotrienes as part of the immediate allergic response.[12]

Synthesis

[edit | edit source]

The multi-step synthesis has been described in the literature.[15]

See also

[edit | edit source]

References

[edit | edit source]
  1. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  2. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  3. ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  4. ^ US 3326924, Villani FJ, Caldwell W, "Azatadine", issued Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value). 
  5. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  6. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  7. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  8. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  9. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  10. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  11. ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  12. ^ a b Lawrence M. Du Buske: Clinical comparison of histamine H1–receptor antagonist drugs. In: Journal of Allergy and Clinical Immunology, Bd. 98, Nr. 6, 1996, S. S307-S318, doi:10.1016/S0091-6749(96)80116-3
  13. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  14. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  15. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).